Gene therapy for breast cancer

被引:11
作者
Boxhorn, HKE [1 ]
Eck, SL [1 ]
机构
[1] Univ Penn, Med Ctr, Dept Med, Div Hematol & Oncol, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/S0889-8588(05)70014-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gene therapy for breast cancer is still in the very early stages of development. Many of the molecular strategics that have been proposed are also being developed for other cancers. Their application to breast cancer, however, needs to address several issues specific to this disease such as the widespread nature of metastases the indolent growth of the tumor cells, and the production by the tumor of immunosuppressive agents. Nonetheless, these approaches appear promising, particularly those that employ a combination of strategies. Gene therapies that affect the biology of breast cancer cells or regulate host immun mechanisms have bren most successful and may be paired with existing therapies for breast cancer.
引用
收藏
页码:665 / +
页数:12
相关论文
共 65 条
[1]   Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through upregulation of the plasminogen/plasmin system [J].
Albo, D ;
Berger, DH ;
Wang, TN ;
Hu, XL ;
Rothman, V ;
Tuszynski, GP .
SURGERY, 1997, 122 (02) :493-499
[2]  
AYLSWORTH CF, 1984, J NATL CANCER I, V72, P637
[3]   Interaction between the adhesion receptor, CD44, and the oncogene product, p185(HER2), promotes human ovarian tumor cell activation [J].
Bourguignon, LYW ;
Zhu, HB ;
Chu, A ;
Iida, N ;
Zhang, L ;
Hung, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :27913-27918
[4]  
BOXHORN HKE, 1998, IN PRESS CANC IMMUNO, V46
[5]  
BRUNDA MJ, 1980, J IMMUNOL, V124, P2682
[6]  
Calder Philip C., 1995, Life Sciences, V56, P455
[7]  
CARTER CA, 1983, CANCER RES, V43, P3559
[8]   TUMOR IMMUNOGENICITY DETERMINES THE EFFECT OF B7 COSTIMULATION ON T-CELL-MEDIATED TUMOR-IMMUNITY [J].
CHEN, LP ;
MCGOWAN, P ;
ASHE, S ;
JOHNSTON, J ;
LI, YW ;
HELLSTROM, I ;
HELLSTROM, KE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :523-532
[9]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[10]   FUNCTIONAL EXPRESSION OF HUMAN-CD28 IN MURINE T-CELL HYBRIDOMAS [J].
COUEZ, D ;
PAGES, F ;
RAGUENEAU, M ;
NUNES, J ;
KLASEN, S ;
MAWAS, C ;
TRUNEH, A ;
OLIVE, D .
MOLECULAR IMMUNOLOGY, 1994, 31 (01) :47-57